Literature DB >> 11705002

The management of metastatic differentiated thyroid carcinoma.

S I Sherman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11705002     DOI： 10.1023/a:1010074930254

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  46 in total

Review 1.  Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.

Authors:  H R Maxon; H S Smith
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

2.  Thyroid cancer dosimetry using clearance fitting.

Authors:  E E Furhang; S M Larson; P Buranapong; J L Humm
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

3.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

Review 4.  An overview of the management of papillary and follicular thyroid carcinoma.

Authors:  E L Mazzaferri
Journal:  Thyroid       Date:  1999-05       Impact factor: 6.568

5.  The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Authors:  R W Tsang; J D Brierley; W J Simpson; T Panzarella; M K Gospodarowicz; S B Sutcliffe
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

6.  131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma.

Authors:  J C Sisson; T J Giordano; D A Jamadar; E A Kazerooni; B Shapiro; M D Gross; S A Zempel; S A Spaulding
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

7.  Prognosis and treatment of brain metastases in thyroid carcinoma.

Authors:  A C Chiu; E S Delpassand; S I Sherman
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

Review 8.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

9.  Locally invasive papillary thyroid carcinoma: 1940-1990.

Authors:  T V McCaffrey; E J Bergstralh; I D Hay
Journal:  Head Neck       Date:  1994 Mar-Apr       Impact factor: 3.147

10.  Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.

Authors:  D S Cooper; B Specker; M Ho; M Sperling; P W Ladenson; D S Ross; K B Ain; S T Bigos; J D Brierley; B R Haugen; I Klein; J Robbins; S I Sherman; T Taylor; H R Maxon
Journal:  Thyroid       Date:  1998-09       Impact factor: 6.568
View more
  3 in total

1.  Challenging cases in thyroid cancer: a multidisciplinary approach.

Authors:  Michael Tuttle; Richard Robbins; Steven M Larson; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-10       Impact factor: 9.236

Review 2.  Spinal metastasis in thyroid cancer.

Authors:  Sami Ramadan; Mohamed A Ugas; Richard J Berwick; Manisha Notay; Hyongyu Cho; Waseem Jerjes; Peter V Giannoudis
Journal:  Head Neck Oncol       Date:  2012-06-25

3.  Papillary thyroid carcinoma with lung metastasis arising from dyshormonogenetic goiter: a case report.

Authors:  Ersin Sukru Erden; Cenk Babayigit; Ramazan Davran; Mustafa Akin; Sinem Karazincir; Nebihe Isaogullari; Mesut Demirkose; Sebahat Genc
Journal:  Case Rep Med       Date:  2013-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.